A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.

A new study found that overweight and obese people had a lower risk of death after developing dementia.

Award to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial ...

Maria Shriver, founder of the Women’s Alzheimer’s Movement, talked about how less than 20 percent of women realized that ...

By Jordan Rau and KFF Health News HealthDay ReportersTHURSDAY, Oct. 1, 2026 (HealthDay News) — In December 2024, Marjorie ...

Andrea Imrie, 82, died a week after she fell and sustained catastrophic head injuries at Murray Royal Hospital in Perth.

The Community School common room buzzed on a recent Thursday morning. Sixth- and seventh-graders adjusted their goggles and ...

New treatments that can slow the progression of Alzheimer's disease could provide significant lifetime benefits to patients and society, with even greater benefits when initiated earlier, according to ...

Decades before the first symptoms of Alzheimer's disease appear, some changes associated with the disease may begin to leave ...

Agitation has a negative impact on the quality of life of patients with Alzheimer’s disease, according to 97% of their ...

People who are overweight or obese when they are diagnosed with dementia are likely to live longer than those in a normal ...

Not all researchers are convinced that the brain changes detected via MRI are robust enough to become a diagnostic tool. But ...